Reltech Diagnostics Private Limited
Provides diagnostic services with registered office in Patna, Bihar.
2017 | Patna, Bihar (India) | Active
Reltech Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.15 M
- Company Age 7 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Ebitda
- Net Worth 67.07%
- Total Assets -20.14%
About Reltech Diagnostics
Reltech Diagnostics Private Limited (RDPL) is a Private Limited Indian Non-Government Company incorporated in India on 21 November 2017 (Seven years and three months 7 days old ). Its registered office is in Patna, Bihar, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.15 M, as per Ministry of Corporate Affairs (MCA) records.
Manoj Pandit, Ajeet Kumar, and Bipul Singh serve as directors at the Company.
Company Details
- Location
Patna, Bihar, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74999BR2017PTC036331
- Company No.
036331
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Nov 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Patna
Industry
Healthcare
Who are the key members and board of directors at Reltech Diagnostics?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manoj Pandit  | Director | 21-Nov-2017 | Current |
| Ajeet Kumar | Director | 21-Nov-2017 | Current |
| Bipul Singh | Director | 21-Nov-2017 | Current |
Financial Performance of Reltech Diagnostics.
Reltech Diagnostics Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth Soared by an impressive increase of 67.07%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Reltech Diagnostics?
In 2020, Reltech Diagnostics had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Reltech Diagnostics?
Unlock and access historical data on people associated with Reltech Diagnostics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Reltech Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Reltech Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.